|
EZE-Gluc to Identify At-Risk Patients
This technology is a functional test to assess which patients will have toxicity to drugs that use the same transporters as ezetimibe glucuronide, or EZE-Gluc. By administering ezetimibe, a commonly used drug, as a predictive diagnostic tool, healthcare providers can gauge the likelihood of treatment success for various medications. The key lies in...
Published: 7/25/2024
|
Inventor(s): Nathan Cherrington
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Medical Devices > Diagnostic
|
|
Elisa Test for EZE-Gluc (EZE-MASH)
This innovation is an ELISA assay test designed to help identify patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH) by measuring levels of ezetimibe glucuronide, or EZE-Gluc, in urine. EZE-Gluc is a byproduct of the drug ezetimibe, which is processed differently in people with MASH, resulting in higher levels of EZE-Gluc in their...
Published: 7/25/2024
|
Inventor(s): Nathan Cherrington
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Medical Devices > Diagnostic
|
|
ARTHUR (Autonomous Remote Telesurgery for Healing in Underserved Regions)
This invention introduces the ability to perform laser-based wound debridement remotely using computer vision and AI. The invention pioneers the remote execution of such procedures, offering a glimpse into a future where medical interventions can be conducted from a distance, potentially revolutionizing healthcare accessibility and efficiency. This...
Published: 9/5/2024
|
Inventor(s): Geoffrey Gurtner
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Biologics, Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Healthcare Portfolios > Dermatology, Technology Classifications > Software & Information Technology > Health IT, Technology Classifications > Software & Information Technology > Mobile Application, Technology Classifications > Software & Information Technology > Human Machine Interface
|
|
Autologous Cell Therapy for Diabetes Mellitus
This technology is the development of novel insulin-producing cells by using preadipocytes from the same animal, which can be autografted. Because the cells are isolated from a small amount of fat from the same organism, the chance of immune rejection is nonexistent. These preadipocytes undergo terminal differentiation into mature adipocytes, which...
Published: 4/3/2023
|
Inventor(s): Ravi Goyal, Sean Limesand
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity
|
|
Organoid Models of Pituitary Adenomas
This technology is a patient-derived organoid of a pituitary adenoma for the purpose of identifying treatment for Cushing’s Disease (CD). The lack of specificity of current standard of care treatments with low efficacy and tolerability makes CD a medical therapeutic challenge. One major limitation to developing new medical therapies is the lack...
Published: 11/16/2023
|
Inventor(s): Yana Zavros, Andrew Little
Keywords(s):
Category(s): Technology Classifications > Research Tools, Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity
|
|
MC4R Selective Ligand for Obesity and Alzheimer’s Disease Prevention
This technology is a novel peptide that has been shown to be a potent MC4R selective antagonist. It is a potential therapeutic for cognitive loss and obesity.
Background:
The challenges of neurodegradation, Alzheimer’s disease, and obesity have been shown to have some similar molecular signatures that contribute to disease and have thus created...
Published: 3/12/2024
|
Inventor(s): Minying Cai, Victor Hruby
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Neurology > CNS & Neurosciences, Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Small Molecules
|
|
Health Behavior Change for Prediabetes
This Family Consultation (FAMCOM) for Prediabetes Program is a health behavior change program for use with adult couples in which at least one member is prediabetic. FAMCOM is an evidenced-based treatment that is effective in modifying a range of health behaviors and has been adapted for prediabetes. The program uses systemic perspective to target couple-level...
Published: 3/12/2024
|
Inventor(s): David Sbarra, Atina Manvelian, Bonita Sur, Mark Whisman
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity
|
|
Advanced Engineered Formulations of Suramin Microparticles and Nanoparticles for Drug Delivery and Applications Therein
This invention consists of new advanced formulations of the drug Suramin for administration by multiple routes. In addition, the invention surrounds the process and manufacturing of these newly formulated Suramin microparticles and nanoparticles so they can be effectively used in the treatment of wounds. Specifically, these new formulations would be...
Published: 11/16/2023
|
Inventor(s): Heidi Mansour, Rick Schnellmann, Maria Acosta
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Radiology, Technology Classifications > Life Sciences > Drug Delivery
|
|
Baro-Balloon
This invention is a new medical device designed to replace permanent and invasive methods of weight loss. The device itself is a series of balloons used to gradually decrease the space in the stomach to promote weight loss. Unlike current gastric balloon based interventions that are free-floating and meant to only be utilized in the short term, this...
Published: 11/16/2023
|
Inventor(s): Seda Bourikian
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Medical Devices > Therapeutic
|
|
Sweat Biomarkers as an Indication of Physiological Conditions
Inventors at the University of Arizona have devised a means by which cortisol isomer ratios in human sweat can be measured and used to evaluate the physiological or psychological state of the patient. Certain cortisol isomer ratios are associated with particular conditions or disorders (high blood pressure, sleep disruption, and others). Other ratios...
Published: 11/16/2023
|
Inventor(s): Esther Sternberg, Min Jia
Keywords(s):
Category(s): Technology Classifications > Research Tools, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Sensors & Controls > Biologic, Technology Classifications > Medical Devices > Diagnostic
|
